DUBLIN--(BUSINESS WIRE)--The "Global Diagnostics Imaging Market (2021-2027) By Product, Application, End Users and Geography, Impact of Covid-19, Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.
Diagnostics Imaging includes variety of non-invasive methods for scanning and examining the body for diagnostics and treatment purposes. The imaging techniques are also used for post-treatment check-ups.
The Global Diagnostics Imaging Market is estimated to be USD 29.6 Bn in 2021 and is expected to reach USD 43.93 Bn in 2027, growing at a CAGR of 6.8%.
Growth of the market is attributed to the increasing demand for early diagnosis and increasing scope of clinical applications, rapidly increasing geriatric population, increasing investment and funding by PPP.
The market is hampered due to a high cost of equipment, increasing regulatory burden and limitations associated with the standalone systems. Emerging countries in the APAC and Africa are creating opportunities for market players. Furthermore, adoption of AI, Analytics and Blockchain in the medical technology is also creating various growth opportunities in the market.
Oncology diagnostics imaging accounts for largest market share due to the increasing prevalence of the diseases.
By products, MRI systems holds largest market share of Global Diagnostics Imaging Market. The growth of the segment is attributed to the high adoption of MRI systems and the need for early diagnostics.
North America is expected to have largest market share in the world and is expected to grow during the forecasted period. The market is expected to grow due to technological advances, higher affordability, increasing number of registered cases in the USA, Canada and Mexico.
The Asia Pacific region is expected to grow at highest CAGR owing to the improving healthcare systems, increasing investment in the region.
- Rapidly growing geriatric population and the subsequent increase in the prevalence of associated diseases
- Increasing demand for early diagnosis and increasing scope of clinical applications
- Technological advancements in diagnostic imaging modalities
- Increasing Investments, funds, and grants by Public-Private Organizations
- High cost of equipment
- Increasing regulatory burden and declining reimbursement
- Limitations associated with standalone systems
- Emerging economies
- Adoption of AI and Analytics in diagnostics Imaging
- Use of Blockchain
- Contract-based Solutions
- GE Healthcare
- Koninklijke Philips N.V.
- Siemens Healthineers
- Canon Inc.
- Hitachi, Ltd.
- Shimadzu Corporation
- Carestream Health
- Esaote SPA
- FUJIFILM Holdings Corporation
- Samsung Electronics Co., Ltd.
- Agfa-Gevaert N.V.
For more information about this report visit https://www.researchandmarkets.com/r/dzk9yg